(Alliance News) - The FTSE 100 edged down on Friday, on a mixed day for European equities, despite new optimism for an end to the war between Russia and Ukraine. Read More
(Alliance News) - GSK PLC on Friday said it will receive an upfront payment of USD370 million from CureVac BV, following a patent settlement involving BioNTech SE and Pfizer Inc over messenger ribonucleic acid vaccine technology. Read More
(Alliance News) - London stocks were called to open higher on Friday, as new data showed soft retail footfall figures during July and US President Donald Trump selected his economic advisor Stephen Miran to fill a Federal Reserve board vacancy. Read More
(Alliance News) - The FTSE 100 sank on Friday after US President Donald Trump announced tariffs on dozens of trading partners, and weak US jobs data fuelled concerns as to the strength of the US economy. Read More
(Alliance News) - The FTSE 100 struggled for direction on Wednesday, despite progress elsewhere, as investors digested another earnings deluge and looked ahead to the US rate call and earnings from technology titans Meta Platforms and Microsoft. Read More
(Alliance News) - The FTSE 100 went into the afternoon lower on Wednesday, though blue-chip peers in Europe were on the up and stocks in New York are called to open higher with a decisive few days on the horizon stateside. Read More
(Alliance News) - GSK said it expects annual sales growth at the top end of its outlook range, after "another quarter of excellent performance" saw revenue and profit beat forecasts. Read More
(Alliance News) - GSK predicted an annual outturn at the top end of guidance, BAE Systems maintained its outlook, while Aston Martin softened its profit forecast. Read More
(Alliance News) - Equities in Europe started the week strongly, after the US and EU agreed a trade deal and on hope that the Donald Trump administration can extend a tariff pause with China. Read More
(Alliance News) - GSK PLC on Monday said it has teamed up with China's Jiangsu Hengrui Pharmaceuticals Co Ltd in a deal worth up to USD12 billion to develop 12 medicines. Read More
(Alliance News) - GSK announced a partnership with China's Hengrui, Cranswick said it expects results in line with market expectations, while STV warned of an annual outcome below consensus. Read More
(Alliance News) - GSK PLC on Thursday said its Blenrep blood cancer treatment has been approved in Europe, as it awaits a final decision from the US regulator. Read More
(Alliance News) - GSK PLC on Wednesday said the US Food & Drug Administration has extended the review period for Blenrep combinations in relapsed/refractory multiple myeloma after an advisory committee last week voted against the overall benefit/risk profile of the drug. Read More
(Alliance News) - Stock prices in London closed higher on Friday, with markets maintaining the optimism that prevailed after US President Donald Trump said on Wednesday that it was "highly unlikely" that he would fire Federal Reserve Chair Jerome Powell. Read More
(Alliance News) - Stock prices in Europe were largely higher at midday on Friday, though the FTSE 100 pared some earlier gains as a slump from GSK weighed on the index. Read More
(Alliance News) - Stock prices in Europe opened higher early on Friday, with the FTSE 100 almost hitting a new record high, as a swathe of dealmaking was well-received in London. Read More